TD Waterhouse Canada’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

TD Waterhouse Canada’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-700	Closed	-$14.9K	–	2023
2024 Q1	$14.9K	Hold	700	–	–	﹤0.01%	1285
2023 Q4	$5.92K	Hold	700	–	–	﹤0.01%	1350
2023 Q3	$1.68K	Hold	700	–	–	﹤0.01%	1511
2023 Q2	$3.23K	Hold	700	–	–	﹤0.01%	1467
2023 Q1	$2.63K	Sell	700 -175	-20%	-$689	﹤0.01%	1482
2022 Q4	$3.01K	Hold	875	–	–	﹤0.01%	1435
2022 Q3	$2.85K	Hold	875	–	–	﹤0.01%	1451
2022 Q2	$2.33K	Hold	875	–	–	﹤0.01%	1521
2022 Q1	$7.16K	Hold	875	–	–	﹤0.01%	1394
2021 Q4	$4.52K	Buy	+875	New	+$5.46K	﹤0.01%	1469

TD Waterhouse Canada's FUSN Position: Q2 2024 in Review

TD Waterhouse Canada sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 700 shares — an estimated $14.9K sold.

TD Waterhouse Canada first reported a position in FUSN in Q4 2021 and held it in 10 quarters. The position peaked at $14.9K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

TD Waterhouse Canada reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
TD Waterhouse Canada sold 700 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $14.9K.
TD Waterhouse Canada first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2021 and held it in 10 quarters.
TD Waterhouse Canada's Fusion Pharmaceuticals Inc. Common Shares position peaked at $14.9K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on TD Waterhouse Canada's 13F filing for Q2 2024, filed 2 Aug 2024.